Katkin Keith is a director of Emergent Biosolutions Inc.
Person profile
Roles
Address
Irvine, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Syndax Pharmaceuticals Inc
9 Feb 24
4
Emergent BioSolutions Inc.
30 May 23
4
Eledon Pharmaceuticals, Inc.
2 May 23
4
Syndax Pharmaceuticals Inc
3 Feb 23
4
Eledon Pharmaceuticals, Inc.
2 Feb 23
4
Syndax Pharmaceuticals Inc
7 Oct 22
4
Syndax Pharmaceuticals Inc
4 Oct 22
4
Emergent BioSolutions Inc.
5 Apr 22
3
Emergent BioSolutions Inc.
5 Apr 22
4
Syndax Pharmaceuticals Inc
3 Feb 22
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
25 May 23 | EBS Emergent Biosolutions | Common Stock | Grant | Acquire A | No | No | 0 | 33,847 | 0.00 | 42,442 |
1 May 23 | ELDN Eledon Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 2.3 | 752,185 | 1.73 mm | 752,185 |
2 Feb 23 | SNDX Syndax Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 16,000 | 0.00 | 48,000 |
1 Feb 23 | ELDN Eledon Pharmaceuticals | Stock Option Common Stock | Grant | Acquire A | No | No | 3.08 | 20,000 | 61.60 k | 20,000 |
6 Oct 22 | SNDX Syndax Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 25.9009 | 9,117 | 236.14 k | 32,000 |
6 Oct 22 | SNDX Syndax Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 8.93 | 9,117 | 81.41 k | 41,117 |
6 Oct 22 | SNDX Syndax Pharmaceuticals | Common Stock | Sell | Dispose S | No | Yes | 25.9009 | 20,782 | 538.27 k | 32,000 |
6 Oct 22 | SNDX Syndax Pharmaceuticals | Common Stock | Option exercise | Acquire M | No | No | 7.88 | 20,782 | 163.76 k | 52,782 |
6 Oct 22 | SNDX Syndax Pharmaceuticals | Stock Options Common Stock | Option exercise | Dispose M | No | No | 7.88 | 20,782 | 163.76 k | 0 |
6 Oct 22 | SNDX Syndax Pharmaceuticals | Stock Options Common Stock | Option exercise | Dispose M | No | No | 8.93 | 9,117 | 81.41 k | 0 |